Description
Adenine 9–D-arabinofuranoside
| Catalog number: | B2015685 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 50 mg |
| Molecular Weight or Concentration: | 267.24 g/mol |
| Supplied as: | Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20 C |
| Keywords: | Vidarabine |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Isaac BG, Ayer SW, Letendre LJ, Stonard RJ. Herbicidal nucleosides from microbial sources J Antibiot (Tokyo). 1991 Jul;44(7):729-32.
- Momken I, Chabowski A, Dirkx E, Nabben M, Jain SS, McFarlan JT, Glatz JF, Luiken JJ, Bonen A. A new leptin-mediated mechanism for stimulating fatty acid oxidation: a pivotal role for sarcolemmal FAT/CD36 Biochem J. 2017 Jan 1;474(1):149-162.
- Shen W, Kim JS, Mitchell S, Kish P, Kijek P, Hilfinger J. 5-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine Nucleosides Nucleotides Nucleic Acids. 2009;28(1):43-55.
- Bravo CA, Vatner DE, Pachon R, Zhang J, Vatner SF. A Food and Drug Administration-Approved Antiviral Agent that Inhibits Adenylyl Cyclase Type 5 Protects the Ischemic Heart Even When Administered after Reperfusion J Pharmacol Exp Ther. 2016 May;357(2):331-6.
- De Lorenzo MS, Chen W, Baljinnyam E, Carlini MJ, La Perle K, Bishop SP, Wagner TE, Rabson AB, Vatner DE, Puricelli LI, Vatner SF. Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption Aging Cell. 2014 Feb;13(1):102-10.
- Chen J, Hudson E, Chi MM, Chang AS, Moley KH, Hardie DG, Downs SM. AMPK regulation of mouse oocyte meiotic resumption in vitro Dev Biol. 2006 Mar 15;291(2):227-38.
- Iwatsubo K, Bravo C, Uechi M, Baljinnyam E, Nakamura T, Umemura M, Lai L, Gao S, Yan L, Zhao X, Park M, Qiu H, Okumura S, Iwatsubo M, Vatner DE, Vatner SF, Ishikawa Y. Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase Am J Physiol Heart Circ Physiol. 2012 Jun 15;302(12):H2622-8.
- Kishimoto A, Ogura T, Esumi H. A pull-down assay for 5 AMP-activated protein kinase activity using the GST-fused protein Mol Biotechnol. 2006 Jan;32(1):17-21.
- Eubank WB, Reeves RE. Growth inhibition of axenic Entamoeba histolytica by tubercidin and ara-A Am J Trop Med Hyg. 1981 Jul;30(4):900-2.
